Continuous Positive Airway Pressure Treatment, Glycemia, and Diabetes Risk in Obstructive Sleep Apnea and Comorbid Cardiovascular Disease
- 14 April 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 43 (8), 1859-1867
- https://doi.org/10.2337/dc19-2006
Abstract
OBJECTIVE Despite evidence of a relationship among obstructive sleep apnea (OSA), metabolic dysregulation, and diabetes, it is uncertain whether OSA treatment can improve metabolic parameters. We sought to determine effects of long-term continuous positive airway pressure (CPAP) treatment on glycemic control and diabetes risk in patients with cardiovascular disease (CVD) and OSA. RESEARCH DESIGN AND METHODS Blood, medical history, and personal data were collected in a substudy of 888 participants in the Sleep Apnea cardioVascular Endpoints (SAVE) trial in which patients with OSA and stable CVD were randomized to receive CPAP plus usual care, or usual care alone. Serum glucose and glycated hemoglobin A1c (HbA1c) were measured at baseline, 6 months, and 2 and 4 years and incident diabetes diagnoses recorded. RESULTS Median follow-up was 4.3 years. In those with preexisting diabetes (n = 274), there was no significant difference between the CPAP and usual care groups in serum glucose, HbA1c, or antidiabetic medications during follow-up. There were also no significant between-group differences in participants with prediabetes (n = 452) or new diagnoses of diabetes. Interaction testing suggested that women with diabetes did poorly in the usual care group, while their counterparts on CPAP therapy remained stable. CONCLUSIONS Among patients with established CVD and OSA, we found no evidence that CPAP therapy over several years affects glycemic control in those with diabetes or prediabetes or diabetes risk over standard-of-care treatment. The potential differential effect according to sex deserves further investigation.Keywords
Funding Information
- National Health and Medical Research Council (1006501, 1060078)
- Respironics Sleep and Respiratory Research Foundation
- Philips Respironics
This publication has 35 references indexed in Scilit:
- Serum urate levels are unchanged with continuous positive airway pressure therapy for obstructive sleep apnea: a randomized controlled trialSleep Medicine, 2013
- Intermittent Hypoxia Impairs Glucose Homeostasis in C57BL6/J Mice: Partial Improvement with Cessation of the ExposureSleep, 2013
- Sleep Characteristics, Mental Health, and Diabetes RiskDiabetes Care, 2013
- Obstructive sleep apnoea and the risk of type 2 diabetes: A meta‐analysis of prospective cohort studiesRespirology, 2012
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2012
- A Controlled Trial of CPAP Therapy on Metabolic Control in Individuals with Impaired Glucose Tolerance and Sleep ApneaSleep, 2012
- Glycemic Management of Type 2 Diabetes MellitusThe New England Journal of Medicine, 2012
- Translating the A1C Assay Into Estimated Average Glucose ValuesDiabetes Care, 2008
- Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetesThorax, 2007
- The Occurrence of Sleep-Disordered Breathing among Middle-Aged AdultsThe New England Journal of Medicine, 1993